Abbott Laboratories (NYSE: ABT) and Dexcom (NASDAQ: DXCM) are two leading medical device companies that compete against one ...
B.C. has gone from one of the worst public formularies to what I consider to be one of the best. So how did we get here?
Continuous glucose monitoring (CGM) is now the standard of care for people with type 1 diabetes in many countries, but its role in the management of type 2 diabetes is less well established. This is ...
GlobalData on MSN
Tandem secures FDA approval for Control-IQ+ use in pregnancy
The approval is based on findings from the CIRCUIT trial published in JAMA in October 2025.
MedPage Today on MSN
Nearly 30 Serious Injuries Tied to Recalled Insulin Pods, FDA Says
Small internal tears in Omnipod 5 insulin pump pods could lead to underdosing ...
Homegrown athletes are spreading lucha libre, or traditional Mexican wrestling, across the Plains. It’s more than just ...
Sedentary behaviour is associated with an increased risk of cardiovascular disease and all-cause mortality in people with ...
CEO Robert B. Ford remains optimistic about the company's opportunity in the continuous glucose monitor (CGM) market.
Abbott Laboratories stock has been punished hard in 2026, and the question is whether that punishment has overshot the ...
Detailed price information for Intuitive Surg Inc (ISRG-Q) from The Globe and Mail including charting and trades.
Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results